Cargando…

Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy

This study investigated supra- and infratentorial structural gray and white matter (GM, WM) alterations in patients with degenerative cervical myelopathy (DCM) as an indicator of secondary harm due to chronic cervical cord compression and micro trauma. With MRI-based anatomical assessment and subseq...

Descripción completa

Detalles Bibliográficos
Autores principales: Jütten, Kerstin, Mainz, Verena, Schubert, Gerrit Alexander, Fabian Gohmann, Robin, Schmidt, Tobias, Ridwan, Hani, Clusmann, Hans, Mueller, Christian Andreas, Blume, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025145/
https://www.ncbi.nlm.nih.gov/pubmed/33773163
http://dx.doi.org/10.1016/j.nicl.2021.102624
_version_ 1783675452463775744
author Jütten, Kerstin
Mainz, Verena
Schubert, Gerrit Alexander
Fabian Gohmann, Robin
Schmidt, Tobias
Ridwan, Hani
Clusmann, Hans
Mueller, Christian Andreas
Blume, Christian
author_facet Jütten, Kerstin
Mainz, Verena
Schubert, Gerrit Alexander
Fabian Gohmann, Robin
Schmidt, Tobias
Ridwan, Hani
Clusmann, Hans
Mueller, Christian Andreas
Blume, Christian
author_sort Jütten, Kerstin
collection PubMed
description This study investigated supra- and infratentorial structural gray and white matter (GM, WM) alterations in patients with degenerative cervical myelopathy (DCM) as an indicator of secondary harm due to chronic cervical cord compression and micro trauma. With MRI-based anatomical assessment and subsequent voxel-based morphometry analyses, pre- and postoperative volume alterations in the primary motor cortex (MI), the primary somatosensory cortex (SI), the supplementary motor area (SMA), and the cerebellum were analyzed in 43 DCM patients and 20 controls. We assessed disease-related symptom severity by the modified Japanese Orthopaedic Association scale (mJOA). The study also explored symptom severity-based brain volume alterations as well as their association with clinical status. Patients had lower mJOA scores (p = .000) and lower GM volume than controls in SI (p = .016) and cerebellar regions (p = .001). Symptom severity-based subgroup analyses revealed volume reductions in almost all investigated GM ROIs (MI: p = .001; CB: p = .040; SMA: p = .007) in patients with severe clinical symptoms as well as atrophy already present in patients with moderate symptom severity. Clinical symptoms in DCM were associated with cortical and cerebellar volume reduction. GM volume alterations may serve as an indicator of both disease severity and ongoing disease progression in DCM, and should be considered in further patient care and treatment monitoring.
format Online
Article
Text
id pubmed-8025145
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-80251452021-04-13 Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy Jütten, Kerstin Mainz, Verena Schubert, Gerrit Alexander Fabian Gohmann, Robin Schmidt, Tobias Ridwan, Hani Clusmann, Hans Mueller, Christian Andreas Blume, Christian Neuroimage Clin Regular Article This study investigated supra- and infratentorial structural gray and white matter (GM, WM) alterations in patients with degenerative cervical myelopathy (DCM) as an indicator of secondary harm due to chronic cervical cord compression and micro trauma. With MRI-based anatomical assessment and subsequent voxel-based morphometry analyses, pre- and postoperative volume alterations in the primary motor cortex (MI), the primary somatosensory cortex (SI), the supplementary motor area (SMA), and the cerebellum were analyzed in 43 DCM patients and 20 controls. We assessed disease-related symptom severity by the modified Japanese Orthopaedic Association scale (mJOA). The study also explored symptom severity-based brain volume alterations as well as their association with clinical status. Patients had lower mJOA scores (p = .000) and lower GM volume than controls in SI (p = .016) and cerebellar regions (p = .001). Symptom severity-based subgroup analyses revealed volume reductions in almost all investigated GM ROIs (MI: p = .001; CB: p = .040; SMA: p = .007) in patients with severe clinical symptoms as well as atrophy already present in patients with moderate symptom severity. Clinical symptoms in DCM were associated with cortical and cerebellar volume reduction. GM volume alterations may serve as an indicator of both disease severity and ongoing disease progression in DCM, and should be considered in further patient care and treatment monitoring. Elsevier 2021-03-13 /pmc/articles/PMC8025145/ /pubmed/33773163 http://dx.doi.org/10.1016/j.nicl.2021.102624 Text en © 2021 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Jütten, Kerstin
Mainz, Verena
Schubert, Gerrit Alexander
Fabian Gohmann, Robin
Schmidt, Tobias
Ridwan, Hani
Clusmann, Hans
Mueller, Christian Andreas
Blume, Christian
Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title_full Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title_fullStr Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title_full_unstemmed Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title_short Cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
title_sort cortical volume reductions as a sign of secondary cerebral and cerebellar impairment in patients with degenerative cervical myelopathy
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8025145/
https://www.ncbi.nlm.nih.gov/pubmed/33773163
http://dx.doi.org/10.1016/j.nicl.2021.102624
work_keys_str_mv AT juttenkerstin corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT mainzverena corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT schubertgerritalexander corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT fabiangohmannrobin corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT schmidttobias corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT ridwanhani corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT clusmannhans corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT muellerchristianandreas corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy
AT blumechristian corticalvolumereductionsasasignofsecondarycerebralandcerebellarimpairmentinpatientswithdegenerativecervicalmyelopathy